149 related articles for article (PubMed ID: 38554186)
21. A promising prognostic model for predicting survival of patients with HIV-related diffuse large B-cell lymphoma in the cART era.
Chen J; Wu Y; Kang Z; Qin S; Ruan G; Zhao H; Tao X; Xie Z; Peng J
Cancer Med; 2023 Jun; 12(11):12470-12481. PubMed ID: 37081761
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of the International prognostic index with β2-microglobulin, platelet count and red blood cell distribution width: a new prognostic model for diffuse large B-cell lymphoma in the rituximab era.
Chen H; Zhong Q; Zhou Y; Qin Y; Yang J; Liu P; He X; Zhou S; Zhang C; Gui L; Yang S; Zhou L; Shi Y
BMC Cancer; 2022 May; 22(1):583. PubMed ID: 35624433
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of nomograms by radiomic features on ultrasound imaging for predicting overall survival in patients with primary nodal diffuse large B-cell lymphoma.
Deng H; Zhou Y; Lu W; Chen W; Yuan Y; Li L; Shu H; Zhang P; Ye X
Front Oncol; 2022; 12():991948. PubMed ID: 36568168
[TBL] [Abstract][Full Text] [Related]
24. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
25. A Novel and Validated Inflammation-Based Prognosis Score (IBPS) Predicts Outcomes in Patients with Diffuse Large B-Cell Lymphoma.
Liu Y; Sheng L; Hua H; Zhou J; Zhao Y; Wang B
Cancer Manag Res; 2023; 15():651-666. PubMed ID: 37465083
[TBL] [Abstract][Full Text] [Related]
26. A nomogram prognostic index for risk-stratification in diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study.
Cai J; Tian X; Ma S; Zhong L; Li W; Wang L; Guo L; Li Z; Wu Y; Zhong G; Huang H; Xia Z; Xia Y; Liu P; Su N; Fang Y; Zhang Y; Cai Q
Br J Cancer; 2021 Aug; 125(3):402-412. PubMed ID: 34012033
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive analysis of the prognostic implication and immune infiltration of CISD2 in diffuse large B-cell lymphoma.
Zhang C; Lin Q; Li C; Qiu Y; Chen J; Zhu X
Front Immunol; 2023; 14():1277695. PubMed ID: 38155967
[TBL] [Abstract][Full Text] [Related]
28. Development and Validation of a Novel Prognostic Nomogram for CD5-Positive Diffuse Large B-Cell Lymphoma: A Retrospective Multicenter Study in China.
Shen Z; Wang L; Zhang B; Li T; Li D; He C; Xue Y; Wang Y; Li B; Liu Q; Zhang H; Gu W; Wang F; Wang C; Shi Y; Ye J; Zhu T; Miao Y; Huang S; Sang W
Front Oncol; 2021; 11():754180. PubMed ID: 34804942
[TBL] [Abstract][Full Text] [Related]
29. [Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].
Liu SH; Hou XY; Zhang XX; Liu GW; Xin FJ; Wang JG; Zhang DL; Wang DS; Lu Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1059-1066. PubMed ID: 33212554
[No Abstract] [Full Text] [Related]
30. Construction and application of dynamic online nomogram for prognosis prediction of patients with advanced (Stage III/IV) tongue squamous cell carcinoma.
Qin Z; Hu Z; Huang B; Wang F; Pan H; He X; Yin L
J Stomatol Oral Maxillofac Surg; 2023 Oct; 124(5):101477. PubMed ID: 37080357
[TBL] [Abstract][Full Text] [Related]
31. Development of a radiomic-clinical nomogram for prediction of survival in patients with diffuse large B-cell lymphoma treated with chimeric antigen receptor T cells.
Zhou Y; Zhang B; Han J; Dai N; Jia T; Huang H; Deng S; Sang S
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11549-11560. PubMed ID: 37395846
[TBL] [Abstract][Full Text] [Related]
32. Surgery shows survival benefit in patients with primary intestinal diffuse large B-cell lymphoma: A population-based study.
Wang M; Ma S; Shi W; Zhang Y; Luo S; Hu Y
Cancer Med; 2021 May; 10(10):3474-3485. PubMed ID: 33931950
[TBL] [Abstract][Full Text] [Related]
33. A nomogram for predicting survival in patients with advanced (stage III/IV) pancreatic body tail cancer: a SEER-based study.
Shi H; Chen Z; Dong S; He R; Du Y; Qin Z; Zhou W
BMC Gastroenterol; 2022 Jun; 22(1):279. PubMed ID: 35658912
[TBL] [Abstract][Full Text] [Related]
34. Should we use nomograms for risk predictions in diffuse large B cell lymphoma patients? A systematic review.
Jelicic J; Larsen TS; Andjelic B; Juul-Jensen K; Bukumiric Z
Crit Rev Oncol Hematol; 2024 Apr; 196():104293. PubMed ID: 38346460
[TBL] [Abstract][Full Text] [Related]
35. Prognostic nomogram incorporating inflammatory cytokines for overall survival in patients with aggressive non-Hodgkin's lymphoma.
Zhong H; Chen J; Cheng S; Chen S; Shen R; Shi Q; Xu P; Huang H; Zhang M; Wang L; Wu D; Zhao W
EBioMedicine; 2019 Mar; 41():167-174. PubMed ID: 30827933
[TBL] [Abstract][Full Text] [Related]
36. Application of clinical nomograms to predicting overall survival and event-free survival in multiple myeloma patients: Visualization tools for prognostic stratification.
Xu J; Zuo Y; Sun J; Zhou M; Dong X; Chen B
Front Public Health; 2022; 10():958325. PubMed ID: 36324453
[TBL] [Abstract][Full Text] [Related]
37. A nomogram prognostic model for diffuse large B-cell lymphoma based on SUVmax and GNRI in elderly patients.
Li M; Lu H; Fan J; Dai M; Su C
EJHaem; 2023 Nov; 4(4):1030-1041. PubMed ID: 38024603
[TBL] [Abstract][Full Text] [Related]
38. A novel NET-related gene signature for predicting DLBCL prognosis.
Shi H; Pan Y; Xiang G; Wang M; Huang Y; He L; Wang J; Fang Q; Li L; Liu Z
J Transl Med; 2023 Sep; 21(1):630. PubMed ID: 37716978
[TBL] [Abstract][Full Text] [Related]
39. Epidemiological trends and novel prognostic evaluation approaches of patients with stage II-IV colorectal neuroendocrine neoplasms: A population-based study with external validation.
Zhao F; Huang L; Wang Z; Wei F; Xiao T; Liu Q
Front Endocrinol (Lausanne); 2023; 14():1061187. PubMed ID: 36817582
[TBL] [Abstract][Full Text] [Related]
40. The Addition of Ferritin Enhanced the Prognostic Value of International Prognostic Index in Diffuse Large B-Cell Lymphoma.
Shen Z; Zhang S; Zhang M; Hu L; Sun Q; He C; Yan D; Ye J; Zhang H; Wang L; Gu W; Miao Y; Liu Q; Ouyang C; Zhu J; Wang C; Zhu T; Huang S; Sang W
Front Oncol; 2021; 11():823079. PubMed ID: 35127536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
